Brooke S. G. Molina, PhD earned her PhD in clinical psychology at Arizona State University. After completing an internship and postdoctoral training at Western Psychiatric Institute and Clinic of UPMC (WPIC), she joined the psychiatry faculty at the University of Pittsburgh in 1995. Dr. Molina uses a developmental perspective to study the course and treatment of drug and alcohol abuse and the disruptive behavior disorders with a focus on Attention Deficit Hyperactivity Disorder (ADHD). Her research began with a Mentored Scientist Career Development Award from NIAAA in 1995 followed by continuous federal funding. Her greatest area of research concentration has been the longitudinal study of several cohorts of children at high risk for alcoholism and drug abuse due to ADHD. Chief among these studies are the Pittsburgh ADHD Longitudinal Study (PALS) and the longitudinal follow-up of the children in the Multimodal Treatment of ADHD study (the MTA). Other projects have focused on treatments and (currently, with MPI Cecile Ladouceur) on neurocognitive mechanisms underlying ADHD course. Misuse of stimulant medication for ADHD by teens and college students is a recent concern reflected in two ongoing primary care studies. Dr. Molina has produced over 150 publications and has an established history of service to the research community (e.g., journal editorial boards; advisory boards and workgroups; federal grant review panel chair). She is devoted to mentoring the next generation of mental health scientists which is reflected in her various training roles (e.g., Co-Director of the Developmental Alcohol Research Training T32; Co-Director of the Career and Research Development Seminar). She is passionate about conducting collaborative, transdisciplinary science that leads to improved outcomes for children with ADHD and other youth at risk of addiction.
Location: Western Psychiatric Institute and Clinic Auditorium
For More Information: Please contact Frances Patrick at patrickfm@upmc.edu.
Learning Objectives: At the conclusion of this lecture, participants will be able to:
Appreciate magnitude of substance abuse risk for children with ADHD.
Understand potential reasons for increased substance abuse risk for children with ADHD.
Understand the current literature regarding effects of medication treatment on substance abuse prevention.
Continuing Education Credit: The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The University of Pittsburgh School of Medicine designates this educational activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Each physician should only claim credit commensurate with the extent of their participation in the activity. Other health care professionals are awarded .15 continuing education units (CEUs), which are equal to 1.5 contact hours. In accordance with Accreditation Council for Continuing Medical Education requirements on disclosure, information about relationships of presenters with commercial interests (if any) will be included in materials which will be distributed at the time of the conference. WPIC is approved by the American Psychological Association to offer continuing education for psychologists. WPIC maintains responsibility for this program and its contents. This program is being offered for 1.5 continuing education credits.
